Advertisement
News
Subscribe to MDT Magazine News

MLSC invites pitches for capital projects funding

March 10, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

The Massachusetts Life Sciences Center today announced open solicitations for investment requests relating to life sciences-related capital projects beginning in Fiscal Year 2013.

Dendreon Expands Launch of PROVENGE

March 10, 2011 9:37 am | by Bio-Medicine.Org | Comments

SEATTLE, March 10, 2011 /- Dendreon Corporation (Nasdaq: DNDN ) announced today that the U.S. Food and Drug Administration (FDA) approved the remainder of its New Jersey manufacturing facility, allowing the company to significantly increase the availability of PROVENGE®...

TOPICS:

International Prostate Cancer Treatment Expert Dr. David B. Samadi Supports Kenyan Minister of Medical Services, Peter Anyang Nyong'o's Decision to Travel to the U.S. for Pros...

March 10, 2011 9:36 am | by Bio-Medicine.Org | Comments

NEW YORK, March 10, 2011 /- Last Saturday, Kenyan Minister of Medical Services Peter Anyang Nyong'o stepped off a plane and onto Kenyan soil to a hero's welcome.  His return marked the end of a nearly year long struggle with prostate cancer.  Having been met with the harsh...

TOPICS:
Advertisement

Innovations That Could Change the Way We Manufacture

March 10, 2011 7:37 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., March 10, 2011 — Honoring both innovation and manufacturing, the Society of Manufacturing Engineers (SME) today announced the 2011 list of Innovations That Could Change The Way You Manufacture. More

Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart

March 10, 2011 7:34 am | by Bio-Medicine.Org | Comments

HOUSTON, March 10, 2011 /PRNewswire-USNewswire/ -- Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial...

TOPICS:

Exercise Performance in Children and Young Adults with Single Ventricle Heart Disease Improves with Use of Drug for Erectile Dysfunction

March 10, 2011 7:33 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, March 10, 2011 /PRNewswire-USNewswire/ -- Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another possible use -- helping children and young adults with congenital heart disease to better tolerate exercise. Sildenafil significantly...

TOPICS:

GE Discovery ST Installed at Imaging Healthcare Specialists

March 10, 2011 7:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 10, 2011 /- Imaging Healthcare Specialists (IHS) is proud to announce the opening of a new GE Discovery ST PET/CT system at its Laurel imaging facility in Hillcrest.  With the opening of this new scanner, IHS now offers state-of-art PET/CT imaging at two locations,...

TOPICS:

FDA Safety Notification: Mammography Problems at Huntington Radiology in Huntington Park, California

March 10, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

The FDA became aware of problems associated with the quality of mammograms performed at the Huntington Radiology facility, located at the following address...

TOPICS:
Advertisement

Nimbus gets seed funding co-led by Bill Gates

March 10, 2011 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge-based Nimbus Discovery LLC, which uses computational technology to discover novel medicines, said today that it has extended its seed round with an investment by Microsoft Corp. founder Bill Gates, Schrödinger co-founder Richard Friesner and Atlas Ventures.

InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

LOS ANGELES, March 10, 2011 /- InstaCare Corp. (OTC Bulletin Board: ISCR ), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary patent...

TOPICS:

MPO Symposium Offers Medical Device Manufacturers the Opportunity to Tour Plants in Costa Rica

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

RAMSEY, N.J., March 10, 2011 /- As part of a two-day education and networking event, MPO Symposium provides medical device manufacturers rare access to local facilities in and around San Jose, Costa Rica, following a morning of conference sessions on May 11. As part of your conference...

TOPICS:

Remedi SeniorCare Expands Distribution of the Paxitâ„¢ Med-Pass Solution, the New Standard in Medication Administration

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

BALTIMORE, March 10, 2011 /- Remedi SeniorCare®, which is among the nation's largest independent institutional pharmacies, is revolutionizing the long-term care (LTC) pharmacy industry with the Paxit™ med-pass system, its 24-hour unit dose medication administration system...

TOPICS:

Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

WAYLAND, Mass., March 10, 2011 /- Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small...

TOPICS:

PNP Therapeutics Meets Important Financial and Regulatory Objectives in Development of New Cancer Therapies

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

BIRMINGHAM, Ala., March 10, 2011 /- PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham (UAB) — today announced that several major...

TOPICS:

Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, March 10, 2011 /- American Medical Systems® (AMS) (Nasdaq: AMMD ), a leading provider of world-class devices and therapies for male and female pelvic health, today announced the results of a six-month prospective multi-center study of the Elevate® Anterior and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading